Oppenheimer & Co. Inc. lowered its stake in shares of Global Medical REIT Inc. (NYSE:GMRE – Free Report) by 23.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,184 shares of the company’s stock after selling 5,921 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Global Medical REIT were worth $190,000 at the end of the most recent reporting period.
A number of other large investors have also added to or reduced their stakes in GMRE. Bank of New York Mellon Corp lifted its stake in shares of Global Medical REIT by 78.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,183,477 shares of the company’s stock valued at $10,746,000 after acquiring an additional 520,583 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in shares of Global Medical REIT by 788.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 130,560 shares of the company’s stock valued at $1,143,000 after acquiring an additional 115,866 shares during the last quarter. AQR Capital Management LLC lifted its stake in shares of Global Medical REIT by 71.1% in the 2nd quarter. AQR Capital Management LLC now owns 188,931 shares of the company’s stock valued at $1,715,000 after acquiring an additional 78,528 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of Global Medical REIT by 1.2% in the 1st quarter. Vanguard Group Inc. now owns 6,213,404 shares of the company’s stock valued at $54,367,000 after acquiring an additional 76,267 shares during the last quarter. Finally, Royal Fund Management LLC lifted its stake in shares of Global Medical REIT by 89.7% in the 3rd quarter. Royal Fund Management LLC now owns 148,164 shares of the company’s stock valued at $1,469,000 after acquiring an additional 70,066 shares during the last quarter. Institutional investors and hedge funds own 57.52% of the company’s stock.
Global Medical REIT Stock Performance
NYSE GMRE opened at $8.70 on Friday. The company has a market capitalization of $581.16 million, a price-to-earnings ratio of -434.78, a PEG ratio of 1.50 and a beta of 1.25. Global Medical REIT Inc. has a twelve month low of $7.98 and a twelve month high of $11.59. The stock has a fifty day simple moving average of $9.34 and a 200 day simple moving average of $9.23. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 1.26.
Global Medical REIT Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, October 8th. Shareholders of record on Friday, September 20th were issued a dividend of $0.21 per share. The ex-dividend date was Friday, September 20th. This represents a $0.84 dividend on an annualized basis and a yield of 9.66%. Global Medical REIT’s payout ratio is currently -4,197.90%.
Analyst Ratings Changes
GMRE has been the subject of a number of research reports. Alliance Global Partners initiated coverage on Global Medical REIT in a research note on Thursday, September 19th. They issued a “buy” rating and a $12.00 price target for the company. Berenberg Bank initiated coverage on Global Medical REIT in a research note on Friday, October 18th. They issued a “buy” rating and a $11.75 price target for the company.
Read Our Latest Report on Global Medical REIT
Global Medical REIT Profile
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Featured Stories
- Five stocks we like better than Global Medical REIT
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- What Makes a Stock a Good Dividend Stock?
- MarketBeat Week in Review – 11/18 – 11/22
- What is a Dividend King?
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.